Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Vivos Therapeutics Inc. (NASDAQ: VVOS) Founder and Chief Medical Officer Shares Company’s Groundbreaking Work in New Book

Dr. Dave Singh, Vivos Therapeutics Inc. founder and Chief Medical Officer, releases his new book titled Pneumopedics and Craniofacial Epigenetics The book is the product of Dr. Singh’s years of research and is a chronology of Vivo Therapeutics’ strides in innovation The book mainly covers craniofacial growth and developmental Genetics It also highlights the relationship […]

Knightscope Autonomous Security Robot Gets Exposure Boost in Disney+ Episode of ‘Loki’ Series

Knightscope develops and manufactures autonomous security robots that utilize an array of technological tools to patrol and monitor client properties on a 24/7 basis The company’s robots have provided more than a million hours of service to clients since 2015, and recently got high-profile attention through an appearance on the Disney+ streaming superhero series “Loki” […]

Chalice Brands (CSE: CHAL) (OTCQB: CHALF) Article Shares Insight into Cannabis as a Heat-Relief Option

Magazine article plugs cooling-off benefits of cannabis. Science actually points to different physiological mechanisms that allow cannabis to help lower body temperatures. The cannabis cooling article is only one of several offerings in the summer issue of the Chalice magazine. With record heat engulfing the West for the past couple of weeks and temperatures topping […]

Grapefruit USA Inc. (GPFT) Provides Status Update on Joint Venture, Possible Acquisition

Earlier this year, Grapefruit was approached by a Canadian cannabis company about a potential acquisition. A series of events have delayed the process. Final decisions, details should be discussed in the next 30–60 days. Grapefruit USA (OTCQB: GPFT), a premiere, fully licensed, California-based cannabis company, is providing clarification regarding its previously announced potential acquisition transaction […]

Hero Technologies Inc. (HENC) Moves to Strengthen Position in Billion-Dollar Market

Sales milestone represents licensees’ ability to successfully support a safe, accessible and effective adult-use industry Billion-dollar mark was reached despite 60-day shutdown of recreational cannabis industry due to COVID-19 Earlier this year, Hero Technologies formed MassCannabis to explore potential opportunities, projects in the state Late last year, the nonmedical cannabis market in Massachusetts hit a […]

Vegan Sport Icon Venus Williams and PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) Committed to Creating Plant-Based Ecosystem; Empower Consumers to Embrace Plant-Based Living

Venus Williams has demonstrated that a plant-based lifestyle can bring health benefits even for those with a physically demanding lifestyle, such as high-performance athletes PlantX and Williams teamed up to help company’s community adopt and maintain a plant-based lifestyle PlantX committed to becoming a plant-based market leader; demonstrates the ability to engage influential public figures […]

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Targets Anxiety Disorders in Focus of Proprietary Psychedelic Treatments

Decision represents opportunity to help millions suffering from social, generalized anxiety disorders Global markets will reach an estimated $4 billion this year, with significant growth projected looking forward WHO estimates that 1 in 13 adults globally suffer from anxiety; treatment options have slow onset, undesirable side effects Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company […]

 

From Our Blog

Soligenix Inc. (NASDAQ: SNGX) Advances Clinical Credibility with HyBryte Research Publication

April 1, 2026

The publication of clinical research in peer-reviewed journals remains a critical milestone in drug development, offering independent validation and broader visibility for emerging therapies. Soligenix (NASDAQ: SNGX) recently reached such a milestone with the publication of a clinical summary of its HyBryte(TM) therapy, reinforcing the importance of scientific transparency as the company advances treatments for […]

Rotate your device 90° to view site.